amlexanox has been researched along with Stomach Neoplasms in 1 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, S | 1 |
| Guan, J | 1 |
| Chen, M | 1 |
| Wang, W | 1 |
| Li, C | 1 |
| Wang, Y | 1 |
| Cheng, Y | 1 |
| Zhou, Z | 1 |
1 other study available for amlexanox and Stomach Neoplasms
| Article | Year |
|---|---|
Targeting IRF3 as a YAP agonist therapy against gastric cancer.
Topics: Adaptor Proteins, Signal Transducing; Aminopyridines; Animals; Cell Line, Tumor; Cell Nucleus; Cell | 2018 |